Health Care [ 9/12 ] | Health Care Equipment & Supplies [ 46/73 ]
NASDAQ | Common Stock
Sensus Healthcare, Inc. operates as a medical device company that manufactures and sells radiation therapy devices to healthcare providers worldwide.
The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices.
It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters.
The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles.
In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body.
Further, the company distributes laser devices, such as applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos.
It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings.
The company was incorporated in 2010 and is based in Boca Raton, Florida.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 7, 25 | -0.06 Decreased by -160.00% | 0.01 Decreased by -700.00% |
| May 15, 25 | -0.16 Decreased by -214.29% | 0.02 Decreased by -900.00% |
| Feb 5, 25 | 0.09 Decreased by -65.38% | 0.12 Decreased by -25.00% |
| Nov 14, 24 | 0.07 Increased by +177.78% | -0.01 Increased by +800.00% |
| Aug 8, 24 | 0.10 Increased by +600.00% | 0.02 Increased by +400.00% |
| May 9, 24 | 0.14 Increased by +216.67% | -0.05 Increased by +380.00% |
| Feb 8, 24 | 0.26 Increased by +52.94% | 0.12 Increased by +116.67% |
| Nov 9, 23 | -0.09 Decreased by -181.82% | -0.02 Decreased by -350.00% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 7.32 M Decreased by -20.82% | -1.04 M Decreased by -164.33% | Decreased by -14.18% Decreased by -181.25% |
| Mar 31, 25 | 8.34 M Decreased by -21.75% | -2.57 M Decreased by -213.10% | Decreased by -30.82% Decreased by -244.54% |
| Dec 31, 24 | 13.07 M Increased by +3.98% | 1.55 M Decreased by -63.28% | Increased by +11.83% Decreased by -64.68% |
| Sep 30, 24 | 8.84 M Increased by +126.76% | 1.22 M Increased by +183.74% | Increased by +13.75% Increased by +136.93% |
| Jun 30, 24 | 9.24 M Increased by +104.09% | 1.61 M Increased by +524.21% | Increased by +17.45% Increased by +307.86% |
| Mar 31, 24 | 10.66 M Increased by +212.33% | 2.27 M Increased by +220.06% | Increased by +21.33% Increased by +138.44% |
| Dec 31, 23 | 12.57 M Decreased by -4.11% | 4.21 M Increased by +48.82% | Increased by +33.50% Increased by +55.20% |
| Sep 30, 23 | 3.90 M Decreased by -56.74% | -1.45 M Decreased by -179.33% | Decreased by -37.22% Decreased by -283.37% |